Literature DB >> 33528630

[Pharmacological/pharmaceutical counseling in intensive care medicine].

H Hilgarth1,2, M Baehr3, S Kluge4, C König4,3.   

Abstract

Adequate pharmacotherapy in critically ill patients is challenging for many clinicians. Disease-related pathophysiological changes often lead to complex therapy strategies including many intensive care treatments (e.g. invasive ventilation, renal replacement therapy). These measures often influence drug prescribing and dosing. Therefore, in organ dysfunction such as renal and liver impairment reduced drug elimination has to be considered by adapting drug dosing towards elimination rates. Moreover, as intensive care medicine often includes the use of multiple drugs the risk for drug-drug interactions increases. The current article gives an overview about the complexity of individual pharmacotherapy in intensive care units whilst providing information for its clinical implementation.

Entities:  

Keywords:  Drug incompatibility; Drug interactions; Hospital pharmacist; Intensive care; Renal insufficiency

Year:  2021        PMID: 33528630     DOI: 10.1007/s00063-020-00767-z

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  3 in total

1.  Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.

Authors:  Leire Leache; Irene Aquerreta; Azucena Aldaz; Pablo Monedero; Antonio Idoate; Ana Ortega
Journal:  Res Social Adm Pharm       Date:  2019-07-08

2.  Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.

Authors:  B E Bosma; P M L A van den Bemt; P H G J Melief; J van Bommel; S S Tan; N G M Hunfeld
Journal:  Neth J Med       Date:  2018-04       Impact factor: 1.422

3.  On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.

Authors:  Joanna E Klopotowska; Rob Kuiper; Hendrikus J van Kan; Anne-Cornelie de Pont; Marcel G Dijkgraaf; Loraine Lie-A-Huen; Margreeth B Vroom; Susanne M Smorenburg
Journal:  Crit Care       Date:  2010-10-04       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.